Who may benefit from robotic gastrectomy?: A subgroup analysis of multicenter prospective comparative study data on robotic versus laparoscopic gastrectomy
- Authors
- Park, J. M.; Kim, H. I.; Han, S. U.; Yang, H. K.; Kim, Y. W.; Lee, H. J.; An, J. Y.; Kim, M. C.; Park, S.; Song, K. Y.; Oh, S. J.; Kong, S. H.; Suh, B. J.; Yane, D. H.; Ha, T. K.; Hyung, W. J.; Ryu, K. W.
- Issue Date
- Dec-2016
- Publisher
- ELSEVIER SCI LTD
- Keywords
- Gastric cancer; Robotic surgery; Laparoscopy; Surgical outcome
- Citation
- EJSO, v.42, no.12, pp 1944 - 1949
- Pages
- 6
- Journal Title
- EJSO
- Volume
- 42
- Number
- 12
- Start Page
- 1944
- End Page
- 1949
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/6399
- DOI
- 10.1016/j.ejso.2016.07.012
- ISSN
- 0748-7983
1532-2157
- Abstract
- Aims: Robotic gastrectomy for gastric cancer has been proven to be a feasible and safe minimally invasive procedure. However, our previous multicenter prospective study indicated that robotic gastrectomy is not superior to laparoscopic gastrectomy. This study aimed to identify which subgroups of patients would benefit from robotic gastrectomy rather than from conventional laparoscopic gastrectomy. Methods: A prospective multicenter comparative study comparing laparoscopic and robotic gastrectomy was previously conducted. We divided the patients into subgroups according to obesity, type of gastrectomy performed, and extent of lymph node dissection. Surgical outcomes were compared between the robotic and laparoscopic groups in each subgroup. Results: A total of 434 patients were enrolled into the robotic (n = 223) and laparoscopic (n = 211) surgery groups. According to obesity and gastrectomy type, there was no difference in the estimated blood loss (EBL), number of retrieved lymph nodes, complication rate, open conversion rate, and the length of hospital stay between the robotic and laparoscopic groups. According to the extent of lymph node dissection, the robotic group showed a significantly lower EBL than did the laparoscopic group after D2 dissection (P = 0.021), while there was no difference in EBL in patients that did not undergo D2 dissection (P = 0.365). Conclusion: Patients with gastric cancer undergoing D2 lymph node dissection can benefit from less blood loss when a robotic surgery system is used. (C) 2016 Elsevier Ltd, BASO similar to The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > College of Medicine > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/6399)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.